Samsung may finally listen to pushy shareholders 24 Jan 2024 Palliser and other outsiders want the South Korean conglomerate’s defacto holding firm, Samsung C&T, to boost returns. It’s underperformed for years but if a court ruling goes in the favour of group leader Jay Y Lee next month, he’ll have a new reason to listen to agitators.
Exxon activists banished best with vote, not court 22 Jan 2024 The $385 bln oil giant wants a judge to stop a shareholder proposal urging stringent emissions limits from going to a vote. Similar measures failed before. Fighting rather than letting this one fall flat amplifies dissent and echoes past doomed dismissals of investor concerns.
Disney’s Bob Iger falls flat by his own standards 18 Jan 2024 Activist Nelson Peltz wants the $166 bln media company’s shareholders to back his board slate. Iger’s defense as CEO is that Disney is on the right path by taking sports network ESPN direct to viewers and cutting streaming losses. Trouble is, progress looks slim on both measures.
Disney’s angry mob risks doing more harm than good 3 Jan 2024 Boss Bob Iger struck a deal to secure support from Mason Morfit’s ValueAct ahead of a looming proxy fight with Nelson Peltz. Pushy fund Blackwells, meanwhile, has nominated its own directors. The mess is of Iger’s own making, but competing agendas further complicate his job.
Capital Calls: Cevian tries ‘relaxivism’ at UBS 19 Dec 2023 Concise views on global finance: The pushy European investor has bought shares worth around 1.2 bln euros in the Swiss bank, equivalent to a 1.3% stake. Yet it seems happy to sit back and let UBS management execute their strategy.
Uneasy lies the head of Crown Castle 28 Nov 2023 Pushy investor Elliott is again chiding the $47 bln wireless towers operator, urging it to replace CEO Jay Brown. The shares have dragged under his watch, with costly fiber networks partly to blame. As NRG and Citrix sensed, it’s unwise to slam the door twice on the hedge fund.
Two Disney activists aren’t better than one 15 Nov 2023 Mason Morfit’s ValueAct has taken a stake in the $168 bln Magic Kingdom, where it can take its own pushy path or work with fellow cage-rattler Nelson Peltz to shake things up. Dueling campaigns would make boss Bob Iger’s job easier. Tag-teaming doesn’t guarantee success.
Endeavor’s envy could become contagious 7 Nov 2023 The $12 bln talent agency and WWE owner led by Hollywood mogul Ari Emanuel is eyeing options after billionaire François-Henri Pinault paid a rich price for peer CAA. Silver Lake, with 71% of the vote, wants to take it private. A stingy bid risks making minority investors jealous.
Vans owner VF is due a wardrobe refresh 6 Nov 2023 The $6 bln apparel empire’s debt soared as shares sank 40% under its ex-CEO, whose costly deal for Supreme ran counter to its modus operandi. New boss Bracken Darrell’s cost-cutting plan has promise. Selling the streetwear brand and investing in known hits is the best next step.
Telecom Italia rival plan has too many pitfalls 3 Nov 2023 An ex-executive and a fund say the telco could raise 16 bln euros by offloading a Brazilian unit and other assets to slash its debt pile. That would spare it from selling its prized network to KKR. Yet bagging such valuations while executing a multi-step project looks tricky.
Sanofi sickness calls for activist tonic 2 Nov 2023 The pharma group lost nearly $27 bln of market value as it announced more investment in drugs. To keep investors happy, CEO Paul Hudson can sell its consumer business, step up dealmaking and buy back shares. Its long-suffering shareholder L’Oréal has reason to back bold action.
Music fund’s flat deal calls for major key change 25 Oct 2023 Shareholders are pushing Hipgnosis, run by industry veteran Merck Mercuriadis, to overhaul its board and cancel a $440 mln asset sale involving Blackstone. Poor governance and a discount value add weight to their case. A new management team could do better by selling the company.
Disney has a weak hand in activist rematch 9 Oct 2023 The $152 bln media giant promised cost cuts to sate cage-rattler Nelson Peltz earlier this year. But that is slow-going and the stock has since fallen by a quarter while peers are up. Now the activist is back and wants a board seat. A weakened Disney’s best bet: invite him in.
Capital Calls: Deliveroo 14 Sep 2023 Concise views on global finance: The UK food delivery company’s shares rose 5% amid hopes of a potential deal, but a rich takeout looks unlikely.
Capital Calls: Selling Salesforce 15 Aug 2023 Concise views on global finance: After successfully agitating for change at the $200 bln software developer, Jeff Smith’s Starboard and Dan Loeb’s Third Point are offloading their stakes. It’s probably a good time to pocket gains considering the challenges ahead for Big Tech.
South Korea’s rematch with Elliott is a lose-lose 3 Aug 2023 Seoul is challenging a $100 mln arbitration award to Paul Singer’s feisty hedge fund over a Samsung merger in 2015. Accepting defeat will invite more claims against the government but the appeal prolongs an embarrassing national saga. Korea Inc will pay the price.
Austrian bank short attack is watchdog’s nightmare 30 Jun 2023 BAWAG shares fell 8% after hedge fund Petrus said the lender had a shoddy business model and poor governance. Sector-beating returns make it a tough target. But following this year’s bank runs, regulators will fret that such campaigns could become a self-fulfilling prophecy.
Elliott asks too much too soon at NRG 23 Jun 2023 The activist wants the CEO of the $8 bln utility to go, in its second campaign against the company. Both sides see the need for cost cuts, returning capital and refreshing the board. Elliott’s worries about acquisitions are reasonable too. But it’s not yet time for heads to roll.
Toyota shareholders make 15% the new win-win 16 Jun 2023 That’s how few voted against re-electing Chair Akio Toyoda to the board over concerns about independence. He can claim victory but the biggest dip in years of his approval rating is awkward. It puts pressure on the $270 bln carmaker to keep its US shareholders onside.
Brenntag has simple fix for activist feud 14 Jun 2023 The $12 bln German chemicals group is facing a board battle with funds that want it to improve humdrum performance via a breakup. Separating its two units probably makes sense if they can’t both run smoothly. Setting a medium-term deadline to decide would ease the strife.